Single-cell RNA sequencing in dissecting microenvironment of age-related macular degeneration: Challenges and perspectives

Ageing Res Rev. 2023 Sep:90:102030. doi: 10.1016/j.arr.2023.102030. Epub 2023 Aug 5.

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in individuals over the age of 50 years, yet its etiology and pathogenesis largely remain uncovered. Single-cell RNA sequencing (scRNA-seq) technologies are recently developed and have a number of advantages over conventional bulk RNA sequencing techniques in uncovering the heterogeneity of complex microenvironments containing numerous cell types and cell communications during various biological processes. In this review, we summarize the latest discovered cellular components and regulatory mechanisms during AMD development revealed by scRNA-seq. In addition, we discuss the main challenges and future directions in exploring the pathophysiology of AMD equipped with single-cell technologies. Our review underscores the importance of multimodal single-cell platforms (such as single-cell spatiotemporal multi-omics and single-cell exosome omics) as new approaches for basic and clinical AMD research in identifying biomarker, characterizing cellular responses to drug treatment and environmental stimulation.

Keywords: Age-related macular degeneration; Microenvironment; Retina; Single-cell RNA sequencing; Transcriptome.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Humans
  • Macular Degeneration* / metabolism
  • Sequence Analysis, RNA

Substances

  • Biomarkers